Article Text

other Versions


Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade
  1. James A Frank (james.frank{at}
  1. University of California, San Francisco, United States
    1. Jean-Francois Pittet (pittetj{at}
    1. University of California, San Francisco, United States
      1. Charlie Wray (cwray1980{at}
      1. Northern California Institute for Research and Education, United States
        1. Michael A. Matthay (michael.matthay{at}
        1. University of California, San Francisco, United States


          Background: Clinical studies have shown that injurious mechanical ventilation is associated with elevated airspace and plasma levels of interleukin-1β (IL-1β); however, the potential therapeutic value of IL-1 inhibition in acute lung injury has not been thoroughly investigated.

          A study was undertaken to determine if IL-1 signaling is a necessary early event in the pathogenesis of experimental ventilator-induced lung injury (VILI).

          Methods: Mice deficient in IL-1 receptor type 1 (IL1R1) and rats treated with IL-1 receptor antagonist (IL-1Ra) were mechanically ventilated with high tidal volume (30 ml/kg) and the effect of IL-1 signaling blockade on lung injury severity was determined.

          Results: Permeability as measured by radiolabeled albumin flux was significantly lower in IL1R1 null mice compared with wild type mice during injurious ventilation (P<0.05). IL-1Ra significantly decreased protein permeability and pulmonary oedema in rats during injurious ventilation. IL-1Ra also decreased airspace and plasma levels of the chemokine CXCL1 and airspace neutrophils. IL-1Ra decreased expression of NOS2 and ICAM-1 mRNA in whole lung. Bronchoalveolar lavage fluid levels of RTI40, a marker of type I cell injury, were 2.5 times lower in following IL-1Ra treatment (P < 0.05). In isolated type II pneumocytes, IL-1β reduced electrical resistance and increased transepithelial permeability.

          Conclusions: IL-1 contributes to alveolar barrier dysfunction in VILI by promoting lung neutrophil recruitment, and by increasing epithelial injury and permeability. Because preserved alveolar barrier function is associated with better outcomes in patients with acute lung injury, these data support further testing of IL-1Ra for the treatment of acute lung injury.

          • Acute Lung Injury
          • Alveolar Epithelial Cell
          • Blood-Air Barrier
          • Interleukin-1 Receptor Antagonist
          • Tight Junctions

          Statistics from

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

          Linked Articles

          • Airwaves
            Wisia Wedzicha, Editor-in-Chief